A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies.
There has been great interest in genetic risk prediction using risk scores in recent years, however, the utility of scores developed in European populations and later applied to non-European populations has not been successful. The goal of this study was to create a methylation risk score (MRS) for...
Saved in:
| Main Authors: | Bertha A Hidalgo, Bre Minniefield, Amit Patki, Rikki Tanner, Minoo Bagheri, Hemant K Tiwari, Donna K Arnett, Marguerite Ryan Irvin |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Public Library of Science (PLoS)
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/497a6248df3448a8a7ae3bc451ee5293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
by: Bertha A. Hidalgo, et al.
Published: (2021) -
AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.
by: Sarah S Knox, et al.
Published: (2010) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
by: Chloe Goldsmith, et al.
Published: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
by: Chen W, et al.
Published: (2021) -
Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
by: Marguerite R. Irvin, et al.
Published: (2021)